Last reviewed · How we verify
Sofosbuvir and ribavirin
Sofosbuvir and ribavirin is a Small molecule drug developed by Kirby Institute. It is currently FDA-approved. Also known as: Sovaldi, Copegus.
At a glance
| Generic name | Sofosbuvir and ribavirin |
|---|---|
| Also known as | Sovaldi, Copegus |
| Sponsor | Kirby Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Switching Regimen in Treating Cirrhotic HCV GT1b Subjects (PHASE2)
- Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy (PHASE4)
- The Efficacy of Vosevi in Treating DAA-experienced Patients
- DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (PHASE4)
- A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
- Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection (PHASE4)
- Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients (PHASE1, PHASE2)
- A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sofosbuvir and ribavirin CI brief — competitive landscape report
- Sofosbuvir and ribavirin updates RSS · CI watch RSS
- Kirby Institute portfolio CI
Frequently asked questions about Sofosbuvir and ribavirin
What is Sofosbuvir and ribavirin?
Sofosbuvir and ribavirin is a Small molecule drug developed by Kirby Institute.
Who makes Sofosbuvir and ribavirin?
Sofosbuvir and ribavirin is developed and marketed by Kirby Institute (see full Kirby Institute pipeline at /company/kirby-institute).
Is Sofosbuvir and ribavirin also known as anything else?
Sofosbuvir and ribavirin is also known as Sovaldi, Copegus.
What development phase is Sofosbuvir and ribavirin in?
Sofosbuvir and ribavirin is FDA-approved (marketed).
Related
- Manufacturer: Kirby Institute — full pipeline
- Also known as: Sovaldi, Copegus
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing